Skip to content
A425Assembly2021-2022 SessionSame asS105

Require Cancer Genetic Testing Coverage

Official title

“Requires health insurance policies to cover comprehensive genetic screening for ovarian and prostate cancers”

Sponsor Nily RozicAD-25+9 co-sponsorsAffects Finance
Status
In Assembly Committee
Insurance
Impact
7/10
Significant
Passage
0%

Bill progress

Step 2 of 7

In committee · Insurance

What's happening

This bill requires health insurance in New York to fully cover genetic and biomarker testing for ovarian and prostate cancer, with no deductibles or coinsurance.

Why it matters

  1. Expands access to advanced testing. By mandating full insurance coverage for comprehensive genetic and FDA-approved biomarker testing for ovarian and prostate cancer, more patients (and their families) can access cutting-edge diagnostics that may identify cancer risks and guide personalized treatment.

  2. Reduces financial barriers to care. Prohibiting deductibles and coinsurance for this testing ensures that cost will not prevent individuals from getting recommended genetic and biomarker tests, which is particularly important given the high price of these services.

  3. Includes family members in coverage. The bill requires that genetic screening be covered not only for patients but also for their family members, potentially enabling earlier detection or prevention strategies for at-risk relatives.

  4. Prevents genetic discrimination in insurance. The law explicitly prohibits insurers from using genetic test results against family members for coverage purposes, addressing concerns about genetic discrimination and protecting individuals from insurance denial or rate increases based on inherited cancer risk.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Headline styles

Require Cancer Genetic Testing Coverage

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Nily Rozic

Assembly Member · Assembly District 25

Chair, Consumer Affairs and Protection

History

  1. Print number 425a
  2. Amend (t) and recommit to insurance
  3. Referred to insurance
  4. Referred to insurance

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

S105Senate

Cover Genetic Cancer Testing

In Senate Committee · Insurance · Sponsor Roxanne J. Persaud

Impact 8 · Significant0% to pass

Full text

2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

425--A

2021-2022 Regular Sessions

IN ASSEMBLY (Prefiled)

January 6, 2021

Introduced by M. of A. ROZIC, ABINANTI, AUBRY, BRONSON, COLTON, COOK, O'DONNELL, OTIS, SIMON, WEPRIN -- Multi-Sponsored by -- M. of A. BARN- WELL, GUNTHER, PERRY, J. RIVERA -- read once and referred to the Committee on Insurance -- recommitted to the Committee on Insurance in accordance with Assembly Rule 3, sec. 2 -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee

AN ACT to amend the insurance law, in relation to requiring health insurance policies to fully cover comprehensive genetic testing and FDA approved biomarker testing for ovarian and prostate cancers

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. This act shall be known and may be cited as the "Ana Lucia act".

§ 2. Paragraph 11-a of subsection (i) of section 3216 of the insurance law is amended by adding a new subparagraph (C) to read as follows:

(C) (i) Such policy shall provide additional full coverage for comprehensive genetic testing and FDA approved testing based on family or person's history for prostatic and ovarian cancer when recommended by a doctor, a board-certified geneticist or a board-certified genetic counselor. Such coverage shall also be provided after the patient's initial diagnosis. Patients need to know if they carry the genetic or inheritance mutation, which can help to determine possible treatments. Genetic screening shall be covered for prostate and ovarian cancer patients' family members. The genetic result shall not be used against family members that carry the genetic or inheritance mutation for insurance coverage purposes.

(ii) All costs associated with such additional full coverage shall not be subject to annual deductibles and coinsurance but shall be borne solely by the insurer.

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD02824-03-1

§ 3. Paragraph 11-a of subsection (l) of section 3221 of the insurance law is amended by adding a new subparagraph (C) to read as follows:

(C)(i) Such policy shall provide additional full coverage for comprehensive genetic testing and FDA approved testing based on family or person's history for prostatic and ovarian cancer when recommended by a doctor, a board-certified geneticist or a board-certified genetic counselor. Such coverage shall also be provided after the patient's initial diagnosis. Patients need to know if they carry the genetic or inheritance mutation, which can help to determine possible treatments. Genetic screening shall be covered for prostate and ovarian cancer patients' family members. The genetic result shall not be used against family members that carry the genetic or inheritance mutation for insurance coverage purposes.

(ii) All costs associated with such additional full coverage shall not be subject to annual deductibles and coinsurance but shall be borne solely by the insurer.

§ 4. Subsection (z-1) of section 4303 of the insurance law is amended by adding a new paragraph 3 to read as follows:

(3)(A) Such policy shall provide additional full coverage for comprehensive genetic testing and FDA approved testing based on family or person's history for prostatic and ovarian cancer when recommended by a doctor, a board-certified geneticist or a board-certified genetic counselor.

(B) All costs associated with such additional full coverage shall not be subject to annual deductibles and coinsurance but shall be borne solely by the insurer. Such coverage shall also be provided after the patient's initial diagnosis. Patients need to know if they carry the genetic or inheritance mutation, which can help to determine possible treatments. Genetic screening shall be covered for prostate and ovarian cancer patients' family members. The genetic result shall not be used against family members that carry the genetic or inheritance mutation for insurance coverage purposes.

§ 5. This act shall take effect on the sixtieth day after it shall have become a law and shall apply to all policies, contracts and certificates issued, renewed, modified, altered or amended on or after such date.

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.